Literature DB >> 21784156

Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

E R Bychkov1, M R Ahmed, V V Gurevich, J L Benovic, E V Gurevich.   

Abstract

Alterations of multiple G protein-mediated signaling pathways are detected in schizophrenia. G protein-coupled receptor kinases (GRKs) and arrestins terminate signaling by G protein-coupled receptors exerting a powerful influence on receptor functions. Modifications of arrestin and/or GRKs expression may contribute to schizophrenia pathology. Cortical expression of arrestins and GRKs was measured postmortem in control and subjects with schizophrenia or schizoaffective disorder. Additionally, arrestin/GRK expression was determined in elderly patients with schizophrenia and age-matched control. Patients with schizophrenia, but not schizoaffective disorder, displayed a reduced concentration of arrestin and GRK mRNAs and GRK3 protein. Arrestins and GRK significantly decreased with age. In elderly patients, GRK6 was reduced, with other GRKs and arrestins unchanged. A reduced cortical concentration of GRKs in schizophrenia (resembling that in aging) may result in altered G protein-dependent signaling, thus contributing to prefrontal deficits in schizophrenia. The data suggest distinct molecular mechanisms underlying schizophrenia and schizoaffective disorder.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784156      PMCID: PMC3166984          DOI: 10.1016/j.nbd.2011.07.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  75 in total

1.  Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.

Authors:  M Rafiuddin Ahmed; Evgeny Bychkov; Vsevolod V Gurevich; Jeffrey L Benovic; Eugenia V Gurevich
Journal:  J Neurochem       Date:  2007-11-07       Impact factor: 5.372

Review 2.  Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?

Authors:  Elizabeth Scarr; Brian Dean
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

Review 3.  Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Mol Pharmacol       Date:  2008-05-30       Impact factor: 4.436

4.  Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.

Authors:  E R Bychkov; V V Gurevich; J N Joyce; J L Benovic; E V Gurevich
Journal:  Neurobiol Aging       Date:  2006-11-27       Impact factor: 4.673

5.  M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms.

Authors:  Jiansong Luo; John M Busillo; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2008-04-03       Impact factor: 4.436

6.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

7.  Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex.

Authors:  Carlo Colantuoni; Thomas M Hyde; Shruti Mitkus; Andrew Joseph; Leah Sartorius; Claudia Aguirre; Johanna Creswell; Elizabeth Johnson; Amy Deep-Soboslay; Mary M Herman; Barbara K Lipska; Daniel R Weinberger; Joel E Kleinman
Journal:  Brain Struct Funct       Date:  2008-05-10       Impact factor: 3.270

8.  Protein kinase C activity is associated with prefrontal cortical decline in aging.

Authors:  Avis R Brennan; Peixiong Yuan; Dara L Dickstein; Anne B Rocher; Patrick R Hof; Husseini Manji; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2007-10-04       Impact factor: 4.673

9.  Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation.

Authors:  Mohamed Rafiuddin Ahmed; Vsevolod V Gurevich; Kevin N Dalby; Jeffrey L Benovic; Eugenia V Gurevich
Journal:  J Pharmacol Exp Ther       Date:  2008-01-04       Impact factor: 4.030

10.  Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.

Authors:  Cullen L Schmid; Kirsten M Raehal; Laura M Bohn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

View more
  21 in total

1.  Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.

Authors:  Adam J Funk; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-08-19       Impact factor: 4.939

Review 2.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

3.  Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.

Authors:  M Rafiuddin Ahmed; Evgeny Bychkov; Seunghyi Kook; Lilia Zurkovsky; Kevin N Dalby; Eugenia V Gurevich
Journal:  Exp Neurol       Date:  2015-02-14       Impact factor: 5.330

4.  Arrestin 1 and Cone Arrestin 4 Have Unique Roles in Visual Function in an All-Cone Mouse Retina.

Authors:  Janise D Deming; Joseph S Pak; Jung-A Shin; Bruce M Brown; Moon K Kim; Moe H Aung; Eun-Jin Lee; Machelle T Pardue; Cheryl Mae Craft
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

5.  G protein-coupled receptor kinase 5 phosphorylates nucleophosmin and regulates cell sensitivity to polo-like kinase 1 inhibition.

Authors:  Christopher H So; Allison M Michal; Rouzbeh Mashayekhi; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

6.  Arrestin-2 and arrestin-3 differentially modulate locomotor responses and sensitization to amphetamine.

Authors:  Lilia Zurkovsky; Katayoun Sedaghat; M Rafiuddin Ahmed; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Neuropharmacology       Date:  2017-04-15       Impact factor: 5.250

7.  G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).

Authors:  Lingyong Li; Kristoff T Homan; Sergey A Vishnivetskiy; Aashish Manglik; John J G Tesmer; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  J Biol Chem       Date:  2015-03-13       Impact factor: 5.157

8.  Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia.

Authors:  Jill R Glausier; Sohei Kimoto; Kenneth N Fish; David A Lewis
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

9.  Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding.

Authors:  Sergey A Vishnivetskiy; Martin K Ostermaier; Ankita Singhal; Valerie Panneels; Kristoff T Homan; Alisa Glukhova; Stephen G Sligar; John J G Tesmer; Gebhard F X Schertler; Joerg Standfuss; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2013-07-17       Impact factor: 4.315

10.  G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.

Authors:  Thais Rafael Guimarães; Eric Swanson; Julia Kofler; Amantha Thathiah
Journal:  Neuropathol Appl Neurobiol       Date:  2021-07-19       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.